[Pharmacologic properties of 6-aminomethaqualone, a new quinazolinone compound with myotonolytic activity]

Early switch from run-in with targeted to immunotherapy in advanced BRAFV600-positive melanoma: final results of the randomised phase II ImmunoCobiVem trial.

ESMO open·2025

Qualitative Descriptions of Developer Changes or Consistency Over Time.

The chronicle of mentoring & coaching·2025

Early switch from run-in treatment with vemurafenib plus cobimetinib to atezolizumab after 3 months leads to rapid loss of tumour control in patients with advanced BRAFV600-positive melanoma: The ImmunoCobiVem phase 2 randomised trial.

European journal of cancer (Oxford, England : 1990)·2023

Management of partial and non-responding cutaneous squamous cell carcinoma.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021

Checkpoint immunotherapy of cutaneous squamous cell carcinoma in patients suffering from chronic lymphocytic leukaemia: divergent outcomes in two men treated with PD-1 inhibitors.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021

Triazolopyrimidine herbicides are potent inhibitors of Aspergillus fumigatus acetohydroxyacid synthase and potential antifungal drug leads.

Scientific reports·2021

Leave-one-out procedure in the validation of elimination rate constant analysis.

Arzneimittel-Forschung·2012

Pharmacokinetic and myocardial enzyme profiles of two administration routes of epirubicin in breast cancer patients.

Arzneimittel-Forschung·2012

Synthesis, anti-hypertensive effect of a novel angiotensin II AT1 receptor antagonist and its anti-tumor activity in prostate cancer.

Arzneimittel-Forschung·2012

Effect of zeolite nano-materials and artichoke (Cynara scolymus L.) leaf extract on increase in urinary clearance of systematically absorbed nicotine.

Arzneimittel-Forschung·2012

Fluorescence detection of etoposide-loaded nanoparticles by HPLC and pharmacokinetics study.

Arzneimittel-Forschung·2012

Pharmacokinetics and potential advantages of a new oral solution of levothyroxine vs. other available dosage forms.

Arzneimittel-Forschung·2012

Evaluation of Group 1 Metabotropic Glutamate Receptors Expression After Lacosamide Treatment in a Kainic Acid-Induced Temporal Lobe Epilepsy Model.

Turkish neurosurgery·2026

Investigating the molecular mechanisms underlying the neuroprotective potential of ellagic acid in scopolamine-induced learning and memory dysfunction.

Research in pharmaceutical sciences·2026

Clinical and Hematological Correlation of Nail Changes in Type 2 Diabetes Mellitus: A Retrospective Study.

Cureus·2026

Relationship between nanoscale assembly and cytotoxicity in the piperazine amides of betulinic acid: an in vitro study.

RSC medicinal chemistry·2026

Mechanism of action of quinoline-based ionic liquids against the pathogenesis of the fungal pathogen, Candida albicans.

Journal of biosciences·2026

First Spectrofluorimetric Determination of Mirogabalin in Biological Fluids: A Validated Hantzsch Derivatization Strategy With Full NMR Structural Confirmation.

Luminescence : the journal of biological and chemical luminescence·2026

Related Experiment Videos

[Pharmacologic properties of 6-aminomethaqualone, a new quinazolinone compound with myotonolytic activity]

Related Concept Videos

Early switch from run-in with targeted to immunotherapy in advanced BRAFV600-positive melanoma: final results of the randomised phase II ImmunoCobiVem trial.

Qualitative Descriptions of Developer Changes or Consistency Over Time.

Early switch from run-in treatment with vemurafenib plus cobimetinib to atezolizumab after 3 months leads to rapid loss of tumour control in patients with advanced BRAFV600-positive melanoma: The ImmunoCobiVem phase 2 randomised trial.

Management of partial and non-responding cutaneous squamous cell carcinoma.

Checkpoint immunotherapy of cutaneous squamous cell carcinoma in patients suffering from chronic lymphocytic leukaemia: divergent outcomes in two men treated with PD-1 inhibitors.

Triazolopyrimidine herbicides are potent inhibitors of Aspergillus fumigatus acetohydroxyacid synthase and potential antifungal drug leads.

Leave-one-out procedure in the validation of elimination rate constant analysis.

Pharmacokinetic and myocardial enzyme profiles of two administration routes of epirubicin in breast cancer patients.

Synthesis, anti-hypertensive effect of a novel angiotensin II AT1 receptor antagonist and its anti-tumor activity in prostate cancer.

Effect of zeolite nano-materials and artichoke (Cynara scolymus L.) leaf extract on increase in urinary clearance of systematically absorbed nicotine.

Fluorescence detection of etoposide-loaded nanoparticles by HPLC and pharmacokinetics study.

Pharmacokinetics and potential advantages of a new oral solution of levothyroxine vs. other available dosage forms.

Evaluation of Group 1 Metabotropic Glutamate Receptors Expression After Lacosamide Treatment in a Kainic Acid-Induced Temporal Lobe Epilepsy Model.

Investigating the molecular mechanisms underlying the neuroprotective potential of ellagic acid in scopolamine-induced learning and memory dysfunction.

Clinical and Hematological Correlation of Nail Changes in Type 2 Diabetes Mellitus: A Retrospective Study.

Relationship between nanoscale assembly and cytotoxicity in the piperazine amides of betulinic acid: an in vitro study.

Mechanism of action of quinoline-based ionic liquids against the pathogenesis of the fungal pathogen, Candida albicans.

First Spectrofluorimetric Determination of Mirogabalin in Biological Fluids: A Validated Hantzsch Derivatization Strategy With Full NMR Structural Confirmation.

Related Experiment Videos

[Pharmacologic properties of 6-aminomethaqualone, a new quinazolinone compound with myotonolytic activity]

Related Concept Videos

Related Articles